Neutral lipid storage disease (Q40063)

From determinar.ia.br - Determine suas informações
Revision as of 05:43, 13 August 2026 by Determinaradmin (talk | contribs) (‎Changed an Item)
Neutral lipid storage disease (NLSD) refers to a group of diseases characterised by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: NLSD with ichthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.
Language Label Description Also known as
default for all languages
5C52.2
    English
    Neutral lipid storage disease
    Neutral lipid storage disease (NLSD) refers to a group of diseases characterised by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: NLSD with ichthyosis (NLSDI/Dorfman-Chanarin disease) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy) can be distinguished.

      Statements

      CID11:5C52.2
      0 references
      dki-india-5C52.2
      0 references
      Concluído
      0 references
      13 August 2026
      0 references